These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33977099)

  • 61. Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.
    Yu D; Zhuang L; Sun X; Chen J; Yao Y; Meng K; Ding Y
    BMC Cancer; 2007 Jul; 7():122. PubMed ID: 17608955
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.
    Greiner M; Kreutzer B; Jung V; Grobholz R; Hasenfus A; Stöhr RF; Tornillo L; Dudek J; Stöckle M; Unteregger G; Kamradt J; Wullich B; Zimmermann R
    Int J Cancer; 2011 May; 128(10):2284-95. PubMed ID: 20669223
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impaired autophagy response in human hepatocellular carcinoma.
    Bao L; Chandra PK; Moroz K; Zhang X; Thung SN; Wu T; Dash S
    Exp Mol Pathol; 2014 Apr; 96(2):149-54. PubMed ID: 24369267
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma.
    Xue F; Higgs BW; Huang J; Morehouse C; Zhu W; Yao X; Brohawn P; Xiao Z; Sebastian Y; Liu Z; Xia Y; Shen D; Kuziora M; Dong Z; Han H; Gu Y; Gu J; Xia Q; Yao Y
    J Transl Med; 2015 Dec; 13():379. PubMed ID: 26653219
    [TBL] [Abstract][Full Text] [Related]  

  • 65. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
    Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY
    PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.
    Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC
    PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.
    Liu B; Zhang J; Huang C; Liu H
    PLoS One; 2012; 7(8):e43147. PubMed ID: 22912812
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.
    Huang J; Zhang YL; Teng XM; Lin Y; Zheng DL; Yang PY; Han ZG
    BMC Cancer; 2007 Jul; 7():126. PubMed ID: 17626620
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of HAAH/humbug quantitative detection in the diagnosis of hepatocellular carcinoma.
    Xue T; Su J; Li H; Xue X
    Oncol Rep; 2015 Jan; 33(1):329-37. PubMed ID: 25394783
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
    Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma.
    Liu AW; Cai J; Zhao XL; Xu AM; Fu HQ; Nian H; Zhang SH
    J Clin Pathol; 2009 Nov; 62(11):1003-8. PubMed ID: 19861558
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
    PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
    [TBL] [Abstract][Full Text] [Related]  

  • 73. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential expression of genes during aflatoxin B(1)-induced hepatocarcinogenesis in tree shrews.
    Li Y; Wan DF; Su JJ; Cao J; Ou C; Qiu XK; Ban KC; Yang C; Qin LL; Luo D; Yue HF; Zhang LS; Gu JR
    World J Gastroenterol; 2004 Feb; 10(4):497-504. PubMed ID: 14966905
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.
    Qiu W; David D; Zhou B; Chu PG; Zhang B; Wu M; Xiao J; Han T; Zhu Z; Wang T; Liu X; Lopez R; Frankel P; Jong A; Yen Y
    Am J Pathol; 2003 Jun; 162(6):1961-74. PubMed ID: 12759252
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
    Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR
    Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers.
    Lee JI; Lee JW; Kim JM; Kim JK; Chung HJ; Kim YS
    World J Gastroenterol; 2012 Sep; 18(34):4751-7. PubMed ID: 23002345
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
    Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
    J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.
    Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J
    BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.